Nutraceuticals CDMO Market (2026 - 2033)

Nutraceuticals CDMO Market Summary

The global nutraceuticals CDMO market was valued at USD 40.6 billion in 2025 and is projected to grow from USD 43.2 billion in 2026 to USD 72.8 billion in 2033, at a CAGR of 7.1% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 37.0% in 2025. The key factors driving the market are increasing R&D activity, demand for nutraceutical products, and the influx of small- and medium-sized pharmaceutical manufacturers seeking outsourcing partners. 

Moreover, rising emphasis on stronger immunity and overall well-being is pushing demand for dietary supplements, vitamins, and other nutraceuticals, thereby pushing demand for new products. Nutraceuticals are gaining popularity due to the growing demand for organic and natural products that support health and wellness. Advancements in technology, such as the adoption of AI, Robotic Process Automation (RPA), 3-D printing, and Virtual Reality and Augmented Reality, increase efficiency in manufacturing and product formulation. 3D printing techniques in the nutraceutical industry have spurred new ventures aimed at improving drug delivery. Technology enables the use of customizable ingredients to produce products uniquely designed with specific ingredients.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Post-pandemic scenario provides nutraceutical companies with an opportunity to innovate and create products that address emerging health concerns. Moreover, consumers have shown a greater interest in products that support immune function and overall health. Nutraceuticals such as minerals, vitamins, herbal supplements, antioxidants, and functional foods with immune-boosting properties have experienced increased demand.

New product development and investment in research & development are major factors driving growth in the nutraceuticals CDMO market. For instance, in March 2025, SIRIO, a global nutraceutical contract development and manufacturing organization (CDMO), launched its new XtraGummies range featuring high-potency formulations containing ingredients such as omega-3, iron, and creatine. The customizable gummy products were developed to provide consumers with a convenient and enjoyable alternative to traditional tablets and capsules while delivering higher nutritional potency in fewer doses. The launch reflects the growing demand for innovative nutraceutical gummy formats across multiple consumer groups.

Analyst Perspective

The nutraceutical CDMO industry is poised for robust growth, fueled by increased customer preference for health-maintenance products, supplements, and nutritional products. The nutraceutical companies are shifting towards outsourcing for the manufacturing operations, which will facilitate more efficient development & regulatory approval. Going forward, new avenues may arise due to the growing need for personalized nutrition solutions, novel delivery mechanisms such as gummies and softgels, and expansion into new regions. The adoption of advanced manufacturing techniques and research will play a key role in gaining a competitive advantage.

Services Insights

Manufacturing and packaging services dominated the nutraceuticals CDMO market, accounting for the largest revenue share of over 32.0% in 2025. Manufacturing and packaging are essential components of the supply chain. Several companies lack the specialized equipment, infrastructure, or expertise to handle the process effectively and efficiently internally. By outsourcing these services to CDMOs, companies can concentrate on their core competencies. In addition, there are several advantages, such as regulatory compliance, cost-effectiveness, and scalability, which tend to increase the demand for these services. For instance, in April 2025, Robinson Pharma expanded its manufacturing capabilities by adding 10 new softgel production machines and increasing its tablet and capsule production capacity. The expansion was aimed at enhancing large-scale manufacturing efficiency and meeting growing demand from nutraceutical brands for outsourced manufacturing and packaging services.

On the other hand, the product formulation and development segment is anticipated to register a lucrative CAGR of over 8.0% in the nutraceuticals contract development and manufacturing organization (CDMO) market during the forecast period of 2026 to 2033. The high growth of this segment is due to customized formulations, expertise in nutraceutical formulation, regulatory compliance, and cost efficiency and scalability. These services assist companies in creating high-quality and compliant nutraceutical products.

Dosage Form Insights

The tablets & capsule segment dominated the nutraceuticals CDMO market and accounted for the largest revenue share of more than 25.0% in 2025. High shares in the segment are primarily due to the rise in demand for easy, convenient dietary supplements. The advantage of capsules is that they can encapsulate various active ingredients with minimal excipient use. Moreover, capsules also offer additional benefits over alternative dosage forms. They can be produced in attractive color combinations, allowing for product differentiation and branding. They are easy to handle, making them convenient for manufacturers during production and for consumers when consuming the supplements. For instance, in January 2025, Lonza announced the expansion of its hard gelatin capsule manufacturing capacity by adding new production lines at its facilities in Rewari, India, and Suzhou, China. The expansion was undertaken to meet growing demand from the pharmaceutical and nutraceutical industries and enhance the company's ability to supply high-quality capsule dosage forms across regional markets.

The softgel category is poised to witness a substantial CAGR from 2026 to 2033. It is a highly popular method for delivering a wide range of nutraceutical formulations and supplements.  Consumer preferences have shifted towards softgel capsule technology for nutraceutical products due to its patient-centric form. The key factors contributing to the increasing demand for soft gels are the growing awareness among consumers of health supplements and their benefits, and the significant expansion in the number of softgel and nutraceutical manufacturers in the market.

Company Size Insights

The mid-size companies held the largest market share and are expected to register the fastest CAGR over the forecast period. Mid-size companies specializing in nutraceuticals can offer greater customization and flexibility than larger companies. These companies can adapt their processes to meet their clients' specific ingredient sourcing preferences, formulation requirements, and packaging needs. This adaptability enables them to meet the specific requirements of the nutraceutical market, which often demands a wide range of products and formulations.

On the other hand, large companies also hold a significant market share. This is attributed to large-sized companies having substantial infrastructure, including advanced technologies, state-of-the-art manufacturing facilities, and strong quality control systems. Moreover, they have the resources to invest in automation, cutting-edge equipment, and analytical capabilities.

Regional Insights

North America dominated the nutraceuticals CDMO industry, accounting for the largest revenue share of over 37.0% in 2025. The key factors driving market growth in the region are increasing R&D activity and rising consumer demand for nutraceuticals due to their medical benefits. The increasing number of strategic initiatives, such as mergers and acquisitions, geographic expansion, research and development, and manufacturing, are also contributing to the growth of the nutraceuticals CDMO industry in the region. For instance, in June 2025, Cosmos Health entered the U.S. nutraceutical manufacturing market through a strategic agreement with DolCas Biotech. The collaboration enables production at GMP-certified facilities in the U.S. and strengthens the company's manufacturing and commercialization capabilities in the North American nutraceutical sector.

To learn more about this report, Download Free Sample Report

The increasing strategy initiatives such as merger acquisition, geographic expansion, research and development activities, and manufacturing activities are also contributing to the growth of the nutraceuticals CDMO industry in the region. For instance, in June 2021, Innovations in Nutrition + Wellness (INW) acquired Capstone Nutrition, a global manufacturer of high-quality nutrition and wellness product. This acquisition combined two complementary businesses and strengthen INW as a global provider of products such as minerals, vitamins, and supplement categories.

Asia Pacific Nutraceuticals CDMO Market Trends

Asia Pacific is anticipated to register the fastest CAGR of over 9.0% in the Nutraceuticals CDMO industry during the forecast period. The region’s significant growth is driven by rising consumer awareness of the benefits of functional food. Additionally, the growing trend of outsourcing manufacturing and drug development, and advancements in ingredient research and development, are major factors contributing to market growth in the region. Furthermore, India is well poised to become a multi-billion-dollar market in the nutraceutical industry. This is due to the largest & fastest-growing consumer base, and rising awareness of health and fitness among people, especially among youngsters. The adoption of products such as gummies, dissolving strips, chewables, and powdered drink mixes is fueling innovation in the nutraceutical CDMO industry in the region.

Key Nutraceuticals CDMO Company Insights

The major players operating across the nutraceuticals CDMO industry are focused on the adoption of strategic initiatives such as mergers, partnerships, acquisitions, etc. For instance, in April 2025, Lubrizol entered a distribution partnership with Palmer Holland to expand the reach of its nutraceutical ingredient portfolio across the U.S. The partnership is intended to support the development of next-generation dietary supplements and functional nutrition products by improving ingredient accessibility and market coverage.

Key Nutraceuticals CDMO Companies

The following key companies have been profiled for this study on the nutraceuticals CDMO market.

• Catalent Inc.

• Lonza

• NUTRASCIENCE LABS

• Robinson Pharma, Inc.

• Health Wright Products, Inc.

• Innovations in Nutrition + Wellness

• INPHARMA S.p.A.

• Aenova Group

• NutraPakUSA

• SFI Health

Recent Developments

• In August 2025, Sampre Nutrition partnered with Rama Exports in a manufacturing agreement to produce nutraceuticals and food products. Sampre Nutrition will handle manufacturing, supply, quality assurance, and packaging, while Rama Exports will purchase the finished goods over a three-year contract. This agreement is projected to generate approximately USD 2 million (Rs 15 crore) in business, boosting Sampre Nutrition's revenue and strengthening its operations.

• In May 2025, Gummi World expanded beyond its core gummy business by launching high-volume capsule manufacturing, creating a fully integrated platform for gummies and capsules. The move was aimed at providing nutraceutical brands with broader dosage-form options and scalable manufacturing services under one roof.

Global Nutraceuticals CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study. For the purpose of this study, Grand View Research has segmented the global nutraceuticals CDMO market based on dosage form, services, company size, and region.

• Dosage Form Outlook (Revenue, USD Billion, 2021 - 2033)

  • Tablets & Capsules

  • Powder

  • Softgel

  • Others

• Services Outlook (Revenue, USD Billion, 2021 - 2033)

  • Product Formulation and Development

  • Manufacturing and Packaging

  • Research & Development (R&D)

  • Regulatory Compliance

  • Others

• Company Size Outlook (Revenue, USD Billion, 2021 - 2033)

  • Small Companies

  • Mid-Sized Companies

  • Large Companies

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.                

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait